Factors Influencing Cost Several clinical variables influence total treatment cost, including:
Total cell quantity administered, generally ranging from 10 million to 150 million cells
Delivery route, including localized, intravenous, or combined treatment
Number of treatment sites
Imaging guidance requirements
Monitoring and adjunct therapies when indicated
Stem cell therapy is not standardized across all patients. Dosing is individualized and determined by physician evaluation. Comparison With United States Pricing In the United States, regenerative cell-based therapies frequently range between $8,000 and $30,000 depending on the indication and facility. Differences in pricing structures may reflect the regulatory environment, administrative overhead, facility costs, malpractice structures, and distribution chains. Cost differences alone do not determine treatment quality. Laboratory standards, physician oversight, and clinical protocol design should also be considered. Laboratory Verification and Quality Control In cell-based medicine, important quality variables include cell identity, cell viability, cell count, sterility, handling, and storage conditions. Flow cytometry may be used to characterize cell populations and confirm cellular markers associated with mesenchymal stromal cells when appropriate. Patients evaluating stem cell therapy should consider whether dosing is measurable and whether laboratory verification procedures are documented. At Longevity Medical Institute, laboratory processes are integrated into clinical protocol development to support standardized preparation and dosing consistency. Physician-Directed Treatment Planning Stem cell therapy requires medical assessment to determine candidacy, appropriate cell quantity, delivery method, expected risk profile, and adjunct therapies when indicated.
Pricing is provided after consultation and review of medical history and imaging when applicable.
Longevity Medical Institute
10
Made with FlippingBook Ebook Creator